02496nas a2200301 4500000000100000008004100001100001100042700001200053700001100065700001600076700001300092700001500105700001300120700001000133700001100143700001300154700001100167700001600178700001400194700001000208700001500218245016900233250002000402300001100422490000800433520170400441020004902145 2013 d1 aYan L.1 aFeng X.1 aNiu W.1 aLabarthe D.1 aZhang Y.1 aElliott P.1 aZhang J.1 aLi N.1 aShi J.1 aZhang R.1 aChu H.1 aEngelgau M.1 aNeiman A.1 aWu U.1 aNeal Bruce00aA large-scale cluster randomized trial to determine the effects of community-based dietary sodium reduction-the China Rural Health Initiative Sodium Reduction Study a2 November 2013 a815-220 v1663 a

BACKGROUND: Cardiovascular diseases are the leading cause of death and disability in China. High blood pressure caused by excess intake of dietary sodium is widespread and an effective sodium reduction program has potential to improve cardiovascular health. DESIGN: This study is a large-scale, cluster-randomized, trial done in five Northern Chinese provinces. Two counties have been selected from each province and 12 townships in each county making a total of 120 clusters. Within each township one village has been selected for participation with 1:1 randomization stratified by county. The sodium reduction intervention comprises community health education and a food supply strategy based upon providing access to salt substitute. Subsidization of the price of salt substitute was done in 30 intervention villages selected at random. Control villages continued usual practices. The primary outcome for the study is dietary sodium intake level estimated from assays of 24-hour urine. TRIAL STATUS: The trial recruited and randomized 120 townships in April 2011. The sodium reduction program was commenced in the 60 intervention villages between May and June of that year with outcome surveys scheduled for October to December 2012. Baseline data collection shows that randomisation achieved good balance across groups. DISCUSSION: The establishment of the China Rural Health Initiative has enabled the launch of this large-scale trial designed to identify a novel, scalable strategy for reduction of dietary sodium and control of blood pressure. If proved effective, the intervention could plausibly be implemented at low cost in large parts of China and other countries worldwide.

 a1097-6744 (Electronic) - 0002-8703 (Linking)